CrossRef

Untitled

Oncosuppressor-Mutated Cell-Based Diagnostic Platform for Liquid Biopsy Diagnoses Benign Head and Neck Masses and Predicts Malignancy in Thyroid Nodules: Results from a Consecutive Cohort of Patients

European Thyroid Journal 10(4) (2021)

Mohamed Abdouh; Roger Tabah; Vincenzo Arena; Manuel Arena; Zu-hua Gao; Aurelio Lorico; Goffredo Orazio Arena

AZƏRBAYCAN RESPUBLİKASININ ENDEMİK VƏ QEYRİ-ENDEMİK BÖLGƏLƏRİNDƏ QALXANABƏNZƏR VƏZİNİN FOLLİKULYAR NEOPLAZİYASI OLAN XƏSTƏLƏRİN DİAQNOSTİKA VƏ MÜALİCƏSİNƏ DAİR

Azerbaijan Medical Journal(4) (2025)

A.H. Hümmətov; E.T. Məmmədova; M.G. Mahmudov

Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective

Journal of Clinical & Translational Endocrinology 23 (2021)

Adnan Zahid; Waqas Shafiq; Khawaja Shehryar Nasir; Asif Loya; Syed Abbas Raza; Sara Sohail; Umal Azmat

Unveiling the Malignancy Risk of Surgically Treated Bethesda III Thyroid Nodules: A 10-Year Retrospective Study Comparing Fine-Needle Aspiration Cytology (FNAC) and Histopathology

Cureus (2024)

Minhaj Rafi; Muhammad Awais Kanwal; Muhammad Awais; Taha Ahmad; Muhammad Tayyab; Muhammad Saulat Naem; Shayan K Ghaloo; Syed Raza Hussain; Muhammad Faisal

Impact of ultrasound elastography in evaluating Bethesda category IV thyroid nodules with histopathological correlation

Frontiers in Endocrinology 15 (2024)

Monica Latia; Andreea Borlea; Monica Simina Mihuta; Octavian Constantin Neagoe; Dana Stoian

Surgical treatment of the thyroid nodes of uncertain cytological structure

Klinicheskaia khirurgiia 86(5) (2019)

Yu. M. Таrashchenko; А. E. Коvalenko; M. V. Оstafiychuk; I. R. Yanchiі; M. D. Melnyk; G. V. Zelinskaya; Yu. M. Naida

Risk factors associated with disease-specific mortality in papillary thyroid cancer patients with distant metastases

Endocrine 75(3) (2022)

Kamilla Schmitz Nunes; Leandro Luongo Matos; Beatriz Godoi Cavalheiro; Felipe Ferraz Magnabosco; Marcos Roberto Tavares; Marco Aurélio Kulcsar; Ana Oliveira Hoff; Luiz Paulo Kowalski; Ana Kober Leite

Rates and Predictors of Malignancy in Bethesda III and IV Thyroid Nodules: A Prospective Study

Cureus (2024)

Eman Z Azzam; Marwa A Salah; Waleed A Aboelwafa; Rawan M Essam; Maha E Bondok

Incidence, Clinical Characteristics, and Histopathological Results of Atypia of Undermined Significance in a Tertiary Center in UAE

Dubai Diabetes and Endocrinology Journal 27(1) (2021)

Maha Osman Shangab; Azza Abdulaziz Khalifa; Fatheya Al Awadi; Mouza Alsharhan; Alaaeldin Bashier

Đánh giá kết quả phẫu thuật u tuyến giáp có phân loại tế bào học thuộc nhóm BETHESDA IV

Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế(91) (2024)

Bùi Hứa Như Trọng; Phùng Phướng; Nguyễn Trần Thúc Huân; Lê Thanh Huy; Hà Thúc Khánh

Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology

BMC Endocrine Disorders 20(1) (2020)

Busra Yaprak Bayrak; Ahmet Tugrul Eruyar

Untitled

Great Debate: Molecular Testing and Extent of Surgery in Well-Differentiated Thyroid Cancer

Annals of Surgical Oncology 32(7) (2025)

Cord Sturgeon; Ashok R. Shaha; Linwah Yip

Risk of malignancy in thyroid nodules classified as Bethesda categories III, III - subcategories and IV: 2.5 years study

MGM Journal of Medical Sciences 10(1) (2023)

Abeer M Ilyas; Nilam M More; Leena P Naik